Nisa Investment Advisors
AVBP icon

Nisa Investment Advisors’s ArriVent BioPharma AVBP Stock Holding History

Nisa Investment Advisors’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.22K Hold
313
– – ﹤0.01% 2349
2025
Q4 		$6.3K Hold
313
– – ﹤0.01% 2392
2025
Q3 		$5.78K Sell
313
-21
-6% -$413 ﹤0.01% 2409
2025
Q2 		$7.27K Buy
334
+307
+1,137% +$6.38K ﹤0.01% 2374
2025
Q1 		$499 Sell
27
-69
-72% -$1.69K ﹤0.01% 2794
2024
Q4 		$2.56K Buy
96
+69
+256% +$1.98K ﹤0.01% 2415
2024
Q3 		$635 Hold
27
– – ﹤0.01% 2680
2024
Q2 		$501 Buy
+27
New +$481 ﹤0.01% 2686

Other funds holding AVBP

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Nisa Investment Advisors's AVBP Position: Q1 2026 in Review

Nisa Investment Advisors held its ArriVent BioPharma (AVBP) position steady in Q1 2026 at 313 shares worth $7.22K. The position accounts for ﹤0.01% of the portfolio, ranked #2349.

Nisa Investment Advisors first reported a position in AVBP in Q2 2024 and has held it in 8 quarters since. The position peaked at $7.27K in Q2 2025. 139 funds tracked by Wall St. Rank hold AVBP as of Q1 2026.

  • Nisa Investment Advisors held 313 shares of ArriVent BioPharma worth $7.22K as of Q1 2026.
  • Nisa Investment Advisors left its ArriVent BioPharma share count unchanged in Q1 2026.
  • ArriVent BioPharma made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2349 holding.
  • Nisa Investment Advisors first reported a position in ArriVent BioPharma in Q2 2024 and has held it in 8 quarters since.
  • Nisa Investment Advisors's ArriVent BioPharma position peaked at $7.27K in Q2 2025.
  • 139 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.